IDOKOSO

Serial Number 87723247
606

Registration Progress

Application Filed
Dec 15, 2017
Under Examination
Jan 15, 2019
Approved for Publication
Nov 20, 2018
Published for Opposition
Nov 20, 2018
Registered

Trademark Image

IDOKOSO

Basic Information

Serial Number
87723247
Filing Date
December 15, 2017
Published for Opposition
November 20, 2018
Abandonment Date
February 21, 2022
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Feb 21, 2022
Classes
005

Rights Holder

Incyte Holdings Corporation

03
Address
1801 Augustine Cut-Off
Wilmington, DE 19803

Ownership History

Incyte Holdings Corporation

Original Applicant
03
Wilmington, DE

Incyte Holdings Corporation

Owner at Publication
03
Wilmington, DE

Legal Representation

Attorney
Frances M. Jagla

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

46 events
Date Code Type Description Documents
Feb 22, 2022 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Feb 21, 2022 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jul 29, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 28, 2021 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jul 9, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 9, 2021 EXT5 S SOU EXTENSION 5 FILED Loading...
Jan 8, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 6, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 6, 2021 EXT4 S SOU EXTENSION 4 FILED Loading...
Jan 6, 2021 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jul 3, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 1, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 1, 2020 EXT3 S SOU EXTENSION 3 FILED Loading...
Jul 1, 2020 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 12, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 12, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 11, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 11, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 11, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 11, 2020 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Loading...
Apr 11, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 11, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jan 9, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 7, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 7, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 7, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 16, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 12, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 12, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 12, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 15, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 20, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 20, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 31, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 18, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 18, 2018 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Oct 16, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 16, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 15, 2018 ALIE A ASSIGNED TO LIE Loading...
Sep 27, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 30, 2018 CPRA R PRIORITY ACTION WRITTEN Loading...
Mar 30, 2018 GPRA F PRIORITY ACTION E-MAILED Loading...
Mar 30, 2018 GPRN O NOTIFICATION OF PRIORITY ACTION E-MAILED Loading...
Mar 26, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 3, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 19, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of oncological, hematological, inflammatory and autoimmune disorders
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005